Mesa Air Group Reports First Quarter Fiscal 2024 Results
PHOENIX, May 20, 2024 (GLOBE NEWSWIRE) — Mesa Air Group, Inc. (NASDAQ: MESA) (“Mesa” or the “Company”) today reported first quarter fiscal […]
Nicole Robinson Appointed President of DataPath Inc.
PETAH TIKVA, Israel, May 20, 2024 (GLOBE NEWSWIRE) — Gilat Satellite Networks Ltd. (Nasdaq: GILT, TASE: GILT), a worldwide leader […]
Ocugen Announces CSO to Present on Modifier Gene Therapy at International Society for Cell & Gene Therapy 2024
MALVERN, Pa., May 20, 2024 (GLOBE NEWSWIRE) — Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a biotechnology company focused […]
Aveanna to Participate at the UBS Healthcare Services Cape Cod Summit and Jefferies Global Healthcare Conference
ATLANTA, May 20, 2024 (GLOBE NEWSWIRE) — Aveanna Healthcare Holdings Inc. (“Aveanna”) (NASDAQ: AVAH) today announced that its management team […]
Perspective Therapeutics to Present at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) Annual Meeting 2024
SEATTLE, May 20, 2024 (GLOBE NEWSWIRE) — Perspective Therapeutics, Inc. (“Perspective” or “the Company”) (NYSE AMERICAN: CATX), a radiopharmaceutical company that […]
Sono-Tek Announces Year-End FY 2024 Earnings Conference Call
MILTON, N.Y., May 20, 2024 (GLOBE NEWSWIRE) — Sono-Tek Corporation (NASDAQ: SOTK), the leading developer and manufacturer of ultrasonic coating […]
Arqit Quantum Inc. Announces Financial and Operational Results for the First Half of Fiscal Year 2024
$119,000 of revenue for the six month period ended 31 March 2024 with certain prospective deals slipping to the second […]
TFF Pharmaceuticals and Cleveland Clinic to Advance Multivalent Universal Influenza Vaccine Candidates into Preclinical Testing
FORT WORTH, Texas, May 20, 2024 (GLOBE NEWSWIRE) — TFF Pharmaceuticals, Inc (Nasdaq: TFFP) (the “Company” or “TFF Pharmaceuticals”), a […]
Global-e Reports First Quarter 2024 Results
PETAH-TIKVA, Israel, May 20, 2024 (GLOBE NEWSWIRE) — Global-e Online Ltd. (Nasdaq: GLBE) the leader of global Direct-To-Consumer eCommerce enablement, […]
Sol-Gel Reports First Quarter 2024 Financial Results and Provides Corporate Updates
Phase 3 clinical trial of SGT-610 for Gorlin Syndrome with the first patient screened, is ongoing. Sol-Gel and Beimei Pharma […]
